Marshall Wace’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-444,320
Closed -$8.23M 3211
2025
Q3
$8.23M Buy
444,320
+25,191
+6% +$519K 0.01% 991
2025
Q2
$9M Buy
419,129
+63,345
+18% +$1.37M 0.01% 884
2025
Q1
$8.76M Buy
+355,784
New +$8.79M 0.01% 818
2024
Q2
Sell
-55,902
Closed -$1.63M 2747
2024
Q1
$1.63M Buy
+55,902
New +$1.56M ﹤0.01% 1453
2023
Q3
Sell
-5,597
Closed -$245K 2455
2023
Q2
$245K Buy
+5,597
New +$258K ﹤0.01% 2194
2023
Q1
Sell
-16,122
Closed -$641K 2893
2022
Q4
$641K Buy
+16,122
New +$672K ﹤0.01% 2273
2021
Q2
Sell
-8,133
Closed -$396K 2855
2021
Q1
$396K Buy
8,133
+3,126
+62% +$150K ﹤0.01% 2032
2020
Q4
$207K Buy
+5,007
New +$230K ﹤0.01% 1741
2020
Q3
Sell
-44,915
Closed -$1.97M 1764
2020
Q2
$1.97M Buy
+44,915
New +$2.02M 0.01% 802
2019
Q2
Sell
-9,677
Closed -$428K 1603
2019
Q1
$428K Buy
+9,677
New +$368K ﹤0.01% 1179

Other funds holding KIDS

Marshall Wace's KIDS Position: Q4 2025 in Review

Marshall Wace sold out of OrthoPediatrics (KIDS) in Q4 2025, closing a stake of 444,320 shares — an estimated $8.23M sold.

Marshall Wace first reported a position in KIDS in Q1 2019 and held it in 10 quarters. The position peaked at $9M in Q2 2025. 120 funds tracked by Wall St. Rank hold KIDS as of Q4 2025.

  • Marshall Wace reported no remaining OrthoPediatrics position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 444,320 OrthoPediatrics shares in Q4 2025, an estimated $8.23M.
  • Marshall Wace first reported a position in OrthoPediatrics in Q1 2019 and held it in 10 quarters.
  • Marshall Wace's OrthoPediatrics position peaked at $9M in Q2 2025.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.